Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Femoracetabular Impingement | 8 | 2025 | 15 | 2.930 |
Why?
|
| Ketamine | 6 | 2023 | 229 | 1.700 |
Why?
|
| Hip Joint | 8 | 2025 | 50 | 1.270 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 4 | 2023 | 129 | 1.130 |
Why?
|
| Osteoarthritis, Hip | 3 | 2025 | 61 | 1.090 |
Why?
|
| Arthroscopy | 5 | 2024 | 49 | 1.000 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2023 | 79 | 0.940 |
Why?
|
| Physical Therapy Modalities | 3 | 2024 | 45 | 0.760 |
Why?
|
| Orthopedics | 1 | 2023 | 75 | 0.730 |
Why?
|
| Anxiety Disorders | 4 | 2025 | 730 | 0.720 |
Why?
|
| Fractures, Bone | 1 | 2023 | 210 | 0.650 |
Why?
|
| Hearing Disorders | 4 | 2025 | 42 | 0.640 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 111 | 0.590 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 162 | 0.590 |
Why?
|
| Australia | 7 | 2025 | 171 | 0.550 |
Why?
|
| Anxiety | 1 | 2023 | 1001 | 0.500 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 127 | 0.490 |
Why?
|
| Treatment Outcome | 14 | 2025 | 12860 | 0.380 |
Why?
|
| Physical Therapists | 2 | 2022 | 7 | 0.370 |
Why?
|
| Suicide | 2 | 2025 | 198 | 0.350 |
Why?
|
| Quality of Life | 6 | 2023 | 2071 | 0.350 |
Why?
|
| Tissue and Organ Procurement | 2 | 2024 | 253 | 0.320 |
Why?
|
| Humans | 37 | 2025 | 130433 | 0.310 |
Why?
|
| Biomechanical Phenomena | 4 | 2025 | 268 | 0.300 |
Why?
|
| Veterans | 1 | 2020 | 1792 | 0.290 |
Why?
|
| Walking | 3 | 2025 | 213 | 0.270 |
Why?
|
| Organ Preservation | 2 | 2025 | 60 | 0.270 |
Why?
|
| Perfusion | 2 | 2025 | 211 | 0.260 |
Why?
|
| Depression | 4 | 2023 | 1317 | 0.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2025 | 673 | 0.250 |
Why?
|
| Exercise Therapy | 2 | 2025 | 169 | 0.230 |
Why?
|
| Antidepressive Agents | 3 | 2023 | 328 | 0.230 |
Why?
|
| Liver Transplantation | 2 | 2025 | 1136 | 0.230 |
Why?
|
| Perches | 1 | 2025 | 1 | 0.230 |
Why?
|
| Otolithic Membrane | 1 | 2025 | 2 | 0.230 |
Why?
|
| Fishes | 1 | 2025 | 33 | 0.220 |
Why?
|
| Resistance Training | 1 | 2025 | 26 | 0.220 |
Why?
|
| Female | 19 | 2025 | 70291 | 0.210 |
Why?
|
| Hepatocytes | 1 | 2025 | 235 | 0.210 |
Why?
|
| Genetics, Population | 1 | 2025 | 180 | 0.210 |
Why?
|
| Methemoglobinemia | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tissue Donors | 2 | 2024 | 502 | 0.200 |
Why?
|
| Male | 18 | 2025 | 64535 | 0.200 |
Why?
|
| Borneo | 1 | 2023 | 1 | 0.200 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2023 | 22 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 204 | 0.190 |
Why?
|
| Electroencephalography | 3 | 2023 | 853 | 0.190 |
Why?
|
| Liver | 3 | 2025 | 1797 | 0.190 |
Why?
|
| Extremities | 1 | 2023 | 74 | 0.190 |
Why?
|
| Adult | 11 | 2025 | 31128 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 1258 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2024 | 169 | 0.180 |
Why?
|
| Mood Disorders | 1 | 2023 | 125 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 390 | 0.170 |
Why?
|
| Acetabulum | 1 | 2021 | 22 | 0.170 |
Why?
|
| Exercise | 2 | 2025 | 859 | 0.170 |
Why?
|
| Kynurenic Acid | 1 | 2020 | 9 | 0.170 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 9 | 0.170 |
Why?
|
| Emotions | 1 | 2023 | 349 | 0.170 |
Why?
|
| Parkinson Disease | 2 | 2018 | 722 | 0.170 |
Why?
|
| Kynurenine | 1 | 2020 | 24 | 0.170 |
Why?
|
| Torso | 1 | 2020 | 13 | 0.170 |
Why?
|
| Brain | 4 | 2023 | 3191 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 1205 | 0.160 |
Why?
|
| Family | 1 | 2023 | 579 | 0.160 |
Why?
|
| Pelvis | 1 | 2020 | 71 | 0.160 |
Why?
|
| Age of Onset | 1 | 2021 | 598 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 324 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2023 | 381 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2020 | 185 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 276 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 1005 | 0.140 |
Why?
|
| Hallucinations | 1 | 2018 | 26 | 0.140 |
Why?
|
| Occipital Lobe | 1 | 2018 | 35 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 99 | 0.140 |
Why?
|
| Lewy Body Disease | 1 | 2018 | 16 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 178 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 237 | 0.130 |
Why?
|
| Biomarkers | 2 | 2023 | 3395 | 0.120 |
Why?
|
| Adolescent | 6 | 2025 | 20753 | 0.120 |
Why?
|
| Pandemics | 2 | 2023 | 1153 | 0.120 |
Why?
|
| Physicians | 1 | 2023 | 634 | 0.120 |
Why?
|
| Infusions, Intravenous | 3 | 2022 | 545 | 0.120 |
Why?
|
| Child | 7 | 2025 | 26166 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2022 | 5069 | 0.100 |
Why?
|
| Prognosis | 1 | 2022 | 4894 | 0.100 |
Why?
|
| Canada | 2 | 2024 | 322 | 0.100 |
Why?
|
| Cognition | 1 | 2018 | 813 | 0.090 |
Why?
|
| Range of Motion, Articular | 2 | 2024 | 85 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2025 | 351 | 0.090 |
Why?
|
| Middle Aged | 7 | 2025 | 28385 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17615 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 876 | 0.080 |
Why?
|
| Young Adult | 2 | 2021 | 9995 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2021 | 308 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8493 | 0.080 |
Why?
|
| Psychometrics | 2 | 2023 | 668 | 0.080 |
Why?
|
| Syndrome | 2 | 2022 | 1160 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1627 | 0.070 |
Why?
|
| Risk Factors | 3 | 2025 | 10942 | 0.060 |
Why?
|
| Parents | 2 | 2023 | 1103 | 0.060 |
Why?
|
| Liver Function Tests | 1 | 2025 | 98 | 0.060 |
Why?
|
| Acetamides | 1 | 2025 | 43 | 0.060 |
Why?
|
| Fisheries | 1 | 2025 | 5 | 0.060 |
Why?
|
| Population Density | 1 | 2025 | 31 | 0.060 |
Why?
|
| Fresh Water | 1 | 2025 | 15 | 0.060 |
Why?
|
| Rivers | 1 | 2025 | 11 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2025 | 148 | 0.060 |
Why?
|
| Mutation | 1 | 2019 | 6131 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2025 | 70 | 0.050 |
Why?
|
| Ecosystem | 1 | 2025 | 91 | 0.050 |
Why?
|
| Animals | 2 | 2025 | 33907 | 0.050 |
Why?
|
| Electromyography | 1 | 2025 | 139 | 0.050 |
Why?
|
| Stakeholder Participation | 1 | 2024 | 35 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2025 | 159 | 0.050 |
Why?
|
| Methemoglobin | 1 | 2023 | 3 | 0.050 |
Why?
|
| United Kingdom | 1 | 2024 | 255 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2025 | 148 | 0.050 |
Why?
|
| Aged | 4 | 2025 | 20895 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2023 | 78 | 0.050 |
Why?
|
| Family Relations | 1 | 2023 | 75 | 0.050 |
Why?
|
| Death | 1 | 2023 | 78 | 0.050 |
Why?
|
| Brain Death | 1 | 2023 | 74 | 0.050 |
Why?
|
| Confidentiality | 1 | 2023 | 105 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 259 | 0.040 |
Why?
|
| Sex Factors | 1 | 2025 | 1334 | 0.040 |
Why?
|
| Phenethylamines | 1 | 2021 | 16 | 0.040 |
Why?
|
| Arthralgia | 1 | 2022 | 79 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 416 | 0.040 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 245 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 429 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 718 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 259 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 428 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2018 | 43 | 0.040 |
Why?
|
| Creatine | 1 | 2018 | 38 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 50 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3388 | 0.030 |
Why?
|
| Health Personnel | 1 | 2023 | 548 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3033 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 265 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6781 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.030 |
Why?
|
| Genomics | 1 | 2025 | 1619 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 693 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 219 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6190 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 598 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2018 | 529 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1683 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 551 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 556 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2106 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1890 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1080 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6424 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3815 | 0.020 |
Why?
|